Reuters logo
BRIEF-Theravance Biopharma posts Q3 loss of $1.27 per share
November 7, 2017 / 9:58 PM / 14 days ago

BRIEF-Theravance Biopharma posts Q3 loss of $1.27 per share

Nov 7 (Reuters) - Theravance Biopharma Inc

* Theravance biopharma, inc. Reports third quarter 2017 financial results and provides business update

* Q3 revenue $4.3 million versus i/b/e/s view $4.6 million

* Cash, cash equivalents and marketable securities, excluding restricted cash, totaled $434.4 million as of september 30, 2017​

* Qtrly basic and diluted net loss per share $1.27‍​ Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below